Mitesco (MITI) Liabilities from Discontinued Operations (2014 - 2023)
Mitesco (MITI) reported Liabilities from Discontinued Operations of 9955164.0 for Q3 2023, up 363.96% quarter-over-quarter from 2145706.0 in Q4 2022.
Mitesco (MITI) Liabilities from Discontinued Operations (2014 - 2023) Analysis & Trends
Mitesco (MITI) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 9955164.0 in Q3 2023.
- Liabilities from Discontinued Operations for Q3 2023 came in at 9955164.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was 9955164.0 (changed N/A YoY), and the FY2022 annual result was 2145706.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations improved to 9955164.0 in Q3 2023 per MITI's latest filing, from 2145706.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 9955164.0 in Q3 2023 and troughed at 2145706.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Mitesco | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 9.96 Mn |
| Sep 30, 2023 | 9.96 Mn |
| Dec 31, 2022 | 2.15 Mn |
| Dec 31, 2022 | 2.15 Mn |
| Dec 31, 2014 | 3.10 Mn |
| Dec 31, 2014 | 3.10 Mn |